Nanoparticles, Green Tea Chemistry, and a 90% Cell-Survival Signal: How an Indian University Team Is Re-thinking Alzheimer’s Therapy

D — Dopamine

Dopamine is a naturally occurring chemical messenger in the brain that plays a role in:

• memory,
• motivation, and
• normal brain signalling.

In this nanoparticle system, dopamine helps:

• support neuron health, and
• improve the particles’ interaction with brain cells.

T — Tryptophan

Tryptophan is an essential amino acid (a basic building block of proteins) required for normal cell function.

Here, tryptophan contributes to:

• stabilising the nanoparticle structure, and
• improving its biological compatibility with brain cells.

NP — Nanoparticles

The three components—EGCG, dopamine and tryptophan—are chemically combined into a single nanoscale structure, forming EDTNPs.

What EDTNPs do together:

• stop toxic amyloid proteins from forming,
• help break apart existing plaques,
• reduce inflammation inside brain cells, and
• protect neurons from stress-related damage.

B-EDTNPs — what does the “B” add?

To strengthen the therapy further, researchers added BDNF, creating B-EDTNPs.

BDNF — Brain-Derived Neurotrophic Factor

BDNF is a naturally occurring protein in the human brain that:

• supports neuron growth,
• helps brain cells survive injury, and
• plays a key role in learning and memory.

Think of BDNF as a nutrient or fertiliser for brain cells.

By attaching BDNF to the nanoparticles:

• damaged brain cells recovered better,
• neuron survival increased dramatically, and
• memory and learning functions improved in animal models.

This addition explains why cell survival jumped from about 40–50% to nearly 90% in laboratory experiments.

The upgraded formulation, called B-EDTNPs, showed markedly stronger protective and restorative effects in both cellular experiments and animal models. According to the researchers, these nanoparticles not only prevented harmful protein clumps from forming but also helped dismantle existing plaques, reduce inflammation, and improve memory and behaviour in animal studies.

Why this matters:

Alzheimer’s disease remains one of the most intractable neurodegenerative disorders globally, with limited treatment options that largely slow symptoms rather than alter disease progression. A therapy that can simultaneously target toxicity, inflammation, and neuronal repair—even at an experimental stage—signals a potential shift in how future drugs may be designed. Equally important, the work highlights India’s growing capacity to deliver front-line biomedical research by combining nanotechnology, computational biology, and neuroscience within publicly supported institutions.

How the science works (explained simply)

Alzheimer’s damages the brain when sticky protein fragments (amyloid-beta plaques) build up, trigger inflammation, and kill neurons. The new nanoparticles are extremely small carriers that can interact directly with these proteins.

• EGCG helps block and destabilise toxic protein clumps.
• Dopamine and tryptophan support cellular chemistry and survival.
• BDNF, when added, acts like a “fertiliser” for brain cells, helping them grow and recover.

Computational modelling and molecular simulations—led by GBU researcher Dr Nisha Singh—confirmed that these nanoparticles physically bind to amyloid-beta proteins and help break them apart, explaining the dramatic jump in cell survival seen in lab tests.